TheraBiogen, a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms, and migraine headaches, today announced how the company’s recently launched social media campaign is benefitting its Thera Max® Cold and Flu brand.
As part of its “aggressive” social media strategy, TheraBiogen took to the Big Apple, launching its campaign on a billboard in Times Square. The company also posted to YouTube several interview testimonials, which garnered more than 40,000 views to-date. In addition, TheraBiogen CEO Kelly Hickel kicked-off a radio media tour.
TheraBiogen’s recent marketing efforts tail the October launch of the company’s flu product at two large retail pharmacies. TheraBiogen said it believes a number of opportunities will arise from these efforts as it works toward its goal of becoming a leading competitor in over-the-counter medications for cold and flu symptoms.
Thera Max® is an all-natural, non-addictive relief agent that differs from alternative cold and flu medications because it doesn’t contain Zinc, which has demonstrated adverse side-effects. TheraBiogen currently distributes this product in more than 12,000 locations, including Rite-Aid, Food Lion, and several other large drug retailers.
TheraBiogen’s pipeline includes several products under development, including allergy, sore throat, and migraine remedies.
For more information visit www.theramaxrelief.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment